Li Liu

Li Liu

Auto-generated profile, based on publicly available information

Li Liu

Department of Gastroenterology, Ganzhou People’s Hospital (Ganzhou Hospital-Nanfang Hospital, Southern Medical University), China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2025 in Journal of International Medical Research
Verified
Journal Article
Open access
LLLi Liu
Li Liu
PYPeng Ye
Peng Ye
QGQiuping Gu
Qiuping Gu
LZLing Zeng
Ling Zeng
LLLijuan Liang
Lijuan Liang
YWYingfeng Wei
Yingfeng Wei
Objective: To examine the association between metabolic abnormalities and liver fibrosis in patients with chronic hepatitis B and develop a simple predictive index. Methods: In this retrospective cross-sectional study, 288 patients with chronic hepatitis B were evaluated. Significant fibrosis was defined as fibrosis-4 index ≥ 1.45 or liver stiffness ≥ 7.5 kPa. Variables with P < 0.10 in the univariate analysis were entered in a backward stepwise logistic regression. A fibrosis risk index was calculated from the constant term and β coefficients of significant predictors. Diagnostic performance was assessed using receiver operating characteristic curve analysis. Results: Body mass index; fasting plasma glucose, triglyceride, uric acid, and gamma-glutamyl transferase levels; and presence of fatty liver and diabetes were independent predictors of fibrosis. The fibrosis risk index showed excellent discrimination (area under the curve = 0.928, 95% confidence interval: 0.898–0.954). The optimal cutoff (0.000148) yielded 91.6% sensitivity and 76.4% specificity. Conclusion: Metabolic abnormalities are independently associated with liver fibrosis in patients with chronic hepatitis B patients. The fibrosis risk index is a simple, noninvasive tool that identifies high-risk patients for timely intervention.